455 related articles for article (PubMed ID: 33303906)
1. Microbiome dysbiosis in lung cancer: from composition to therapy.
Liu NN; Ma Q; Ge Y; Yi CX; Wei LQ; Tan JC; Chu Q; Li JQ; Zhang P; Wang H
NPJ Precis Oncol; 2020 Dec; 4(1):33. PubMed ID: 33303906
[TBL] [Abstract][Full Text] [Related]
2. Interplay between the lung microbiome and lung cancer.
Mao Q; Jiang F; Yin R; Wang J; Xia W; Dong G; Ma W; Yang Y; Xu L; Hu J
Cancer Lett; 2018 Feb; 415():40-48. PubMed ID: 29197615
[TBL] [Abstract][Full Text] [Related]
3. Airway Microbiota as a Modulator of Lung Cancer.
Goto T
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32357415
[TBL] [Abstract][Full Text] [Related]
4. Microbiome dysbiosis and epigenetic modulations in lung cancer: From pathogenesis to therapy.
Khan FH; Bhat BA; Sheikh BA; Tariq L; Padmanabhan R; Verma JP; Shukla AC; Dowlati A; Abbas A
Semin Cancer Biol; 2022 Nov; 86(Pt 3):732-742. PubMed ID: 34273520
[TBL] [Abstract][Full Text] [Related]
5. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
6. Microbiome: A Supportive or a Leading Actor in Lung Cancer?
Martins D; Mendes F; Schmitt F
Pathobiology; 2021; 88(2):198-207. PubMed ID: 33352574
[TBL] [Abstract][Full Text] [Related]
7. Role of microbiota on lung homeostasis and diseases.
Wang J; Li F; Tian Z
Sci China Life Sci; 2017 Dec; 60(12):1407-1415. PubMed ID: 29019144
[TBL] [Abstract][Full Text] [Related]
8. The microbiome(s) and cancer: know thy neighbor(s).
González-Sánchez P; DeNicola GM
J Pathol; 2021 Jul; 254(4):332-343. PubMed ID: 33723873
[TBL] [Abstract][Full Text] [Related]
9. Host-Microbiome Interaction in Lung Cancer.
Dong Q; Chen ES; Zhao C; Jin C
Front Immunol; 2021; 12():679829. PubMed ID: 34108973
[TBL] [Abstract][Full Text] [Related]
10. Microbiome Changes during Tuberculosis and Antituberculous Therapy.
Hong BY; Maulén NP; Adami AJ; Granados H; Balcells ME; Cervantes J
Clin Microbiol Rev; 2016 Oct; 29(4):915-26. PubMed ID: 27608937
[TBL] [Abstract][Full Text] [Related]
11. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
[TBL] [Abstract][Full Text] [Related]
12. Lung Microbiome as a Treatable Trait in Chronic Respiratory Disorders.
Scialò F; Vitale M; D'Agnano V; Mariniello DF; Perrotta F; Castaldo A; Campbell SFM; Pastore L; Cazzola M; Bianco A
Lung; 2023 Oct; 201(5):455-466. PubMed ID: 37752217
[TBL] [Abstract][Full Text] [Related]
13. Microbiota and lung cancer.
Goto T
Semin Cancer Biol; 2022 Nov; 86(Pt 3):1-10. PubMed ID: 35882258
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota and Hashimoto's thyroiditis.
Virili C; Fallahi P; Antonelli A; Benvenga S; Centanni M
Rev Endocr Metab Disord; 2018 Dec; 19(4):293-300. PubMed ID: 30294759
[TBL] [Abstract][Full Text] [Related]
15. Oncobiome at the Forefront of a Novel Molecular Mechanism to Understand the Microbiome and Cancer.
Astudillo-de la Vega H; Alonso-Luna O; Ali-Pérez J; López-Camarillo C; Ruiz-Garcia E
Adv Exp Med Biol; 2019; 1168():147-156. PubMed ID: 31713170
[TBL] [Abstract][Full Text] [Related]
16. Microbiota abnormalities in inflammatory airway diseases - Potential for therapy.
Gollwitzer ES; Marsland BJ
Pharmacol Ther; 2014 Jan; 141(1):32-9. PubMed ID: 23969226
[TBL] [Abstract][Full Text] [Related]
17. Potential Role of the Lung Microbiome in Shaping Asthma Phenotypes.
Chung KF
Ann Am Thorac Soc; 2017 Nov; 14(Supplement_5):S326-S331. PubMed ID: 29161086
[TBL] [Abstract][Full Text] [Related]
18. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer-A review.
Nagasaka M; Sexton R; Alhasan R; Rahman S; Azmi AS; Sukari A
Crit Rev Oncol Hematol; 2020 Jan; 145():102841. PubMed ID: 31884204
[TBL] [Abstract][Full Text] [Related]
20. The pulmonary microbiome: challenges of a new paradigm.
Costa AN; Costa FMD; Campos SV; Salles RK; Athanazio RA
J Bras Pneumol; 2018; 44(5):424-432. PubMed ID: 30066739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
